Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...
Asıl Yazarlar: | Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
MDPI AG
2020-12-01
|
Seri Bilgileri: | Vaccines |
Konular: | |
Online Erişim: | https://www.mdpi.com/2076-393X/9/1/3 |
Benzer Materyaller
-
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
Yazar:: Robin John Shattock, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01) -
Vaccines’ New Era-RNA Vaccine
Yazar:: Wenshuo Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01) -
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
Yazar:: Bruna Aparecida Souza Machado, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01) -
Advancing mRNA technologies for therapies and vaccines: An African context
Yazar:: Dylan Kairuz, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01) -
Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
Yazar:: Yoann Aldon, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)